Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof
AssigneesNew York University, The Research Foundation for The State University of New York
InventorsAnn Marie Schmidt, Ravichandran Ramasamy, Alexander Shekhtman, Vivek Rai, Michaele B. Manigrasso
Life of this patent
Estimating the term…
Abstract
Amino, amido, and heterocyclic compounds are disclosed. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, diabetes complications, inflammation, and neurodegeneration, obesity, cancer, ischemia/reperfusion injury, cardiovascular disease and other diseases related to RAGE activity.
Claims21
1-131. (canceled)
A method for preventing, treating or ameliorating in a mammal a disease or condition that is causally related to RAGE activity in vivo, which comprises administering to the mammal an effective disease-treating or condition-treating amount of a compound according to formula B-VI:
- or a pharmaceutically acceptable salt, solvate or prodrug thereof or stereoisomers, isotopic variants and tautomers thereof.
Dependencies are inferred from the claim text.